Bridging predictions with experimental reality: In vitro evaluation of phenolic natural products as SARS-CoV-2 exoribonuclease inhibitors.
- DOI
- 10.1016/j.biopha.2025.118588
- Published
- 2025 Nov
- Container
- Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.biopha.2025.118588,
title = {Bridging predictions with experimental reality: In vitro evaluation of phenolic natural products as SARS-CoV-2 exoribonuclease inhibitors.},
author = {Danda M and Chvátalová B and Nečasová D and Křížová I and Ruml T and Rumlová M},
year = {2025},
journal = {Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie},
doi = {10.1016/j.biopha.2025.118588},
url = {https://doi.org/10.1016/j.biopha.2025.118588}
}RIS
TY - JOUR TI - Bridging predictions with experimental reality: In vitro evaluation of phenolic natural products as SARS-CoV-2 exoribonuclease inhibitors. AU - Danda M AU - Chvátalová B AU - Nečasová D AU - Křížová I AU - Ruml T AU - Rumlová M PY - 2025 JO - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie DO - 10.1016/j.biopha.2025.118588 UR - https://doi.org/10.1016/j.biopha.2025.118588 ER -
APA
M, D., B, C., D, N., I, K., T, R., & M, R. (2025). Bridging predictions with experimental reality: In vitro evaluation of phenolic natural products as SARS-CoV-2 exoribonuclease inhibitors.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. https://doi.org/10.1016/j.biopha.2025.118588
Source records
- pubmed · retrieved 2026-09-26T07:45:29.915Z